Merck buying Acceleron Pharma in $11.5B deal

KENILWORTH, New Jersey (AP) — Merck will spend about $11.5 billion to acquire Acceleron Pharma and its treatment for high pressure in vessels that carry blood to the lungs from the heart. Merck will pay $180 per share in cash for each Acceleron share, the Kenilworth, New Jersey, company said Thursday. ...

Google, News